Jennifer Good's Colleagues at Trevi Therapeutics
Jennifer Good's Contact Details
HQ
203-304-2499
203-304-2499
Location
Company
Trevi Therapeutics
Trevi Therapeutics
Jennifer Good's Company Details
Trevi Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on the development and commercialization of the investigational oral therapy Haduvio™ (nalbuphine ER). Trevi is conducting a Phase 2b/3 clinical trial of Haduvio for the treatment of chronic pruritus associated with prurigo nodularis (PN) and a Phase 2 trial for chronic cough in patients with idiopathic pulmonary fibrosis (IPF). These conditions share a common pathophysiology that is mediated through opioid receptors in the central and peripheral nervous systems, and both are areas of high unmet need. Founded in 2011, Trevi is headquartered in New Haven, CT.
Frequently Asked Questions about Jennifer Good
Jennifer Good currently works for Trevi Therapeutics, Inc..
Jennifer Good's role at Trevi Therapeutics, Inc. is President and CEO.
Jennifer Good's email address is ***@trevitherapeutics.com. To view Jennifer Good's full email address, please signup to ConnectPlex.
Jennifer Good works in the Biotechnology industry.
Jennifer Good's colleagues at Trevi Therapeutics are Katherine Takaki, Farrell Simon, Kevin Fitzmaurice, Diane Soli, Joe Carrino, Katherine Takaki, Helena Brett-Smith and others.
Jennifer Good's phone number is 203-304-2499